| # | Drug | Count |
|---|---|---|
| 0 | CAPECITABINE | 8 |
| 1 | BEVACIZUMAB | 5 |
| 2 | OXALIPLATIN | 5 |
| 3 | ADALIMUMAB | 3 |
| 4 | ANAKINRA | 3 |
| 5 | FLUOROURACIL | 3 |
| 6 | FLUOROURACIL CREAM, 0.5% | 3 |
| 7 | LOXAPINE | 3 |
| 8 | MORPHINE | 3 |
| 9 | PREDNISOLONE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIFLUPREDNATE OPHTHALMIC | 1 | 0.0011 |
| 1 | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | 1 | 0.0011 |
| 2 | LOXAPINE | 3 | 0.0008 |
| 3 | AZILSARTAN KAMEDOXOMIL | 1 | 0.0003 |
| 4 | RAMUCIRUMAB | 2 | 0.0003 |
| 5 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE | 1 | 0.0003 |
| 6 | ALPROSTADIL | 1 | 0.0003 |
| 7 | DIFLUPREDNATE | 1 | 0.0003 |
| 8 | ANAKINRA | 3 | 0.0002 |
| 9 | MINOCYCLINE HYDROCHLORIDE | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 3 | 0.0002 |
| 2 | Cannabinoid [EPC] | 1 | 0.0001 |
| 3 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 5 | Phenothiazine [EPC] | 2 | 0.0001 |
| 6 | Epidermal Growth Factor Receptor Antagonist [EPC] | 3 | 0.0001 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 11 | 0.0000 |
| 8 | Androgen [EPC] | 1 | 0.0000 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 5 | 0.0000 |